Author: lappaadm

June 6, 2023 | Fact Sheets, Novel Psychoactive Substances, Substance Abuse, Synthetic Drugs

The Legislative Analysis and Public Policy Association (LAPPA) is monitoring the emergence of novel psychoactive substances (NPS) appearing on the illicit drug market in the United States. The term “novel” does not denote a new, never-before-seen substance but rather a substance that is newly available in the drug market. This fact sheet, the fourth in a series highlighting these potentially dangerous drugs, examines isotonitazene, a synthetic opioid recently classified as a Schedule I controlled substance under the federal Controlled Substances Act....

June 6, 2023 | Opioids, Public Health, Reports & Studies, Substance Abuse

The content of this blog post is part of the USC-Brookings Institute Schaeffer initiative for Health Policy, a partnership between Economic Studies at Brookings and the University of Southern California Schaeffer Center for Health Policy & Economics. Researchers concluded that effects of the opioid epidemic in the United States have been far-reaching, not just in terms of  health impacts, but also as far as implications for the U.S. economy....

May 8, 2023 | News Bites

Each issue of News Bites will highlight unique news articles from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. This newsletter will feature stories that you may have missed but are important to the field....

May 3, 2023 | Controlled Substances, Harm Reduction, K-12 Education, Model Laws, Public Health, Public Safety

Developed in collaboration with the Earl Carl Institute for Legal and Social Policy at Texas Southern University’s Thurgood Marshall School of Law, the Model School Response to Drugs and Drug-related Incidents Act guides states in establishing a consistent and positive response for public schools to best support students who have drug or drug-related incidents on school premises or at school-related functions....

April 24, 2023 | Alcohol, Controlled Substances, Fentanyl, Marijuana, Methamphetamine, Opioids, Prescription Drugs, Public Health, Reports & Studies, Stimulants, Substance Abuse, Synthetic Drugs

The purpose of this report was to assess immediate and sustained changes in overall illicit substance ingestion rates among children younger than six before and during the COVID-19 pandemic and to examine changes by substance type, including amphetamines, benzodiazepines, cannabis, cocaine, ethanol, and, opioids. Researchers concluded that there was a sustained increase in illicit substance ingestion during the pandemic and that additional studies are needed to contextualize these findings in the setting of pandemic-related stress....

April 11, 2023 | Case Law Monitor

Case Law Monitor is the bimonthly case law newsletter of the Legislative Analysis and Public Policy Association (LAPPA). Each issue will highlight unique cases from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. ...

March 15, 2023 | News Bites

Each issue of News Bites will highlight unique news articles from around the United States in the areas of public health and safety, substance use disorders, and the criminal justice system. This newsletter will feature stories that you may have missed but are important to the field....

March 14, 2023 | Controlled Substances, Model Laws, Opioids, Public Health, Substance Abuse, Treatments

The purpose of the  Model Substance Use Disorder Treatment In Emergency Settings Act (Act) is to establish and align mechanisms for maximizing emergency medical settings as intervention points for people who experience a substance use-related emergency, people with substance use disorders, and their families. This Act intends to do so by addressing the barriers to implementing protocols in emergency medical settings that would ensure evidence-based treatment of patients with substance use-related emergencies....